<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Rev Bras Cir Cardiovasc</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Revista Brasileira de Cirurgia Cardiovascular : &#x000f3;rg&#x000e3;o oficial da Sociedade Brasileira de Cirurgia Cardiovascular</journal-title></journal-title-group><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27163422</article-id><article-id pub-id-type="pmc">4614931</article-id><article-id pub-id-type="doi">10.5935/1678-9741.20150043</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Articles</subject></subj-group></article-categories><title-group><article-title>Short-term inspiratory muscle training potentiates the benefits of
aerobic and resistance training in patients undergoing CABG in phase II cardiac
rehabilitation program</article-title><trans-title-group xml:lang="pt"><trans-title>Treinamento muscular inspirat&#x000f3;rio de curto prazo potencializa os
benef&#x000ed;cios do treinamento aer&#x000f3;bico e resistido em pacientes ap&#x000f3;s CRM na fase
II de programa de reabilita&#x000e7;&#x000e3;o card&#x000ed;aca</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hermes</surname><given-names>B&#x000e1;rbara Maria</given-names></name><degrees>PT</degrees><xref ref-type="aff" rid="aff01">1</xref></contrib><contrib contrib-type="author"><name><surname>Cardoso</surname><given-names>Dannuey Machado</given-names></name><degrees>PT, MSc</degrees><xref ref-type="aff" rid="aff02">2</xref></contrib><contrib contrib-type="author"><name><surname>Gomes</surname><given-names>Tiago Jos&#x000e9; Nardi</given-names></name><degrees>PT, MSc</degrees><xref ref-type="aff" rid="aff03">3</xref></contrib><contrib contrib-type="author"><name><surname>dos Santos</surname><given-names>Tamires Daros</given-names></name><degrees>PT</degrees><xref ref-type="aff" rid="aff01">1</xref></contrib><contrib contrib-type="author"><name><surname>Vicente</surname><given-names>Mar&#x000ed;lia Severo</given-names></name><degrees>PT</degrees><xref ref-type="aff" rid="aff01">1</xref></contrib><contrib contrib-type="author"><name><surname>Pereira</surname><given-names>S&#x000e9;rgio Nunes</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff04">4</xref></contrib><contrib contrib-type="author"><name><surname>Barbosa</surname><given-names>Viviane Acunha</given-names></name><degrees>PT, PhD</degrees><xref ref-type="aff" rid="aff05">5</xref></contrib><contrib contrib-type="author"><name><surname>de Albuquerque</surname><given-names>Isabella Martins</given-names></name><degrees>PT, PhD</degrees><xref ref-type="aff" rid="aff05">5</xref><xref ref-type="corresp" rid="c01"/></contrib></contrib-group><aff id="aff01"><label>1</label>Universidade Federal de Santa Maria (UFSM), Santa Maria,
RS, Brazil.</aff><aff id="aff02"><label>2</label>Department of Physiotherapy. Universidade de Santa Cruz
do Sul (UNISC), Santa Cruz do Sul, RS, Brazil.</aff><aff id="aff03"><label>3</label>Department of Physiotherapy. Centro Universit&#x000e1;rio
Franciscano (UNIFRA), Santa Maria, RS, Brazil.</aff><aff id="aff04"><label>4</label>Cardiac Rehabilitation Program. Hospital Universit&#x000e1;rio
de Santa Maria (HUSM), Santa Maria, RF, Brazil and Universidade Federal de Santa
Maria (UFSM), Santa Maria, RS, Brazil.</aff><aff id="aff05"><label>5</label>Department of Physiotherapy and Rehabilitation.
Universidade Federal de Santa Maria (UFSM), Santa Maria, RS, Brazil.</aff><author-notes><corresp id="c01">Correspondence Address: Isabella Martins de Albuquerque, Avenida
Roraima, 1000, Cidade Universit&#x000e1;ria - Bairro Camobi, Santa Maria, RS, Brazil -
Zip code: 97105-900. E-mail: <email>albuisa@gmail.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Jul-Aug</season><year>2015</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Jul-Aug</season><year>2015</year></pub-date><volume>30</volume><issue>4</issue><fpage>474</fpage><lpage>481</lpage><history><date date-type="received"><day>23</day><month>3</month><year>2015</year></date><date date-type="accepted"><day>21</day><month>6</month><year>2015</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Objective</title><p>To investigate the efficiency of short-term inspiratory muscle training
program associated with combined aerobic and resistance exercise on
respiratory muscle strength, functional capacity and quality of life in
patients who underwent coronary artery bypass and are in the phase II
cardiac rehabilitation program.</p></sec><sec><title>Methods</title><p>A prospective, quasi-experimental study with 24 patients who underwent
coronary artery bypass and were randomly assigned to two groups in the Phase
II cardiac rehabilitation program: inspiratory muscle training program
associated with combined training (aerobic and resistance) group (GCR + IMT,
n=12) and combined training with respiratory exercises group (GCR, n=12),
over a period of 12 weeks, with two sessions per week. Before and after
intervention, the following measurements were obtained: maximal inspiratory
and expiratory pressures (PImax and PEmax), peak oxygen consumption (peak
VO<sub>2</sub>) and quality of life scores. Data were compared between
pre- and post-intervention at baseline and the variation between the pre-
and post-phase II cardiac rehabilitation program using the Student's t-test,
except the categorical variables, which were compared using the Chi-square
test. Values of <italic>P</italic>&#x0003c;0.05 were considered statistically
significant.</p></sec><sec><title>Results</title><p>Compared to GCR, the GCR + IMT group showed larger increments in PImax
(<italic>P</italic>&#x0003c;0.001), PEmax (<italic>P</italic>&#x0003c;0.001), peak
VO<sub>2</sub> (<italic>P</italic>&#x0003c;0.001) and quality of life scores
(<italic>P</italic>&#x0003c;0.001).</p></sec><sec><title>Conclusion</title><p>The present study demonstrated that the addition of inspiratory muscle
training, even when applied for a short period, may potentiate the effects
of combined aerobic and resistance training, becoming a simple and
inexpensive strategy for patients who underwent coronary artery bypass and
are in phase II cardiac rehabilitation.</p></sec></abstract><trans-abstract xml:lang="pt"><sec><title>Objetivo:</title><p>Avaliar os efeitos de um programa de treinamento muscular inspirat&#x000f3;rio em
curto prazo associado ao exerc&#x000ed;cio aer&#x000f3;bio e resistido na for&#x000e7;a muscular
respirat&#x000f3;ria, capacidade funcional e qualidade de vida de pacientes
submetidos &#x000e0; cirurgia de revasculariza&#x000e7;&#x000e3;o do mioc&#x000e1;rdio, na Fase II da
Reabilita&#x000e7;&#x000e3;o Card&#x000ed;aca.</p></sec><sec><title>M&#x000e9;todos:</title><p>Trata-se de um estudo quase-experimental, prospectivo, com amostra de 24
pacientes submetidos &#x000e0; cirurgia de revasculariza&#x000e7;&#x000e3;o do mioc&#x000e1;rdio alocados
aleatoriamente para Fase II da Reabilita&#x000e7;&#x000e3;o Card&#x000ed;aca em dois grupos: grupo
de treinamento muscular inspirat&#x000f3;rio associado ao treinamento combinado
(aer&#x000f3;bio e resistido) (GRC + TMI, n=12) e grupo treinamento combinado e
exerc&#x000ed;cios respirat&#x000f3;rios (GRC, n=12) durante um per&#x000ed;odo de 12 semanas, com 2
sess&#x000f5;es semanais. Antes e ap&#x000f3;s a interven&#x000e7;&#x000e3;o, as seguintes mensura&#x000e7;&#x000f5;es foram
obtidas: press&#x000e3;o inspirat&#x000f3;ria e expirat&#x000f3;ria m&#x000e1;xima (PIm&#x000e1;x e PEm&#x000e1;x), consumo
de oxig&#x000ea;nio de pico (VO<sub>2</sub>pico) e escore de qualidade de vida. Os
dados foram comparados entre o momento pr&#x000e9; e p&#x000f3;s-interven&#x000e7;&#x000e3;o na linha de
base e a varia&#x000e7;&#x000e3;o entre o pr&#x000e9; e p&#x000f3;s-programa de reabilita&#x000e7;&#x000e3;o card&#x000ed;aca com
uso do teste t de Student, exceto as vari&#x000e1;veis categ&#x000f3;ricas, que foram
comparadas pelo teste de qui-quadrado. Foi considerado um
<italic>P</italic>&#x0003c;0,05.</p></sec><sec><title>Resultados:</title><p>Comparado ao GRC, o GRC + TMI apresentou maior incremento tanto na PIm&#x000e1;x
(<italic>P</italic>&#x0003c;0,001) quanto na PEm&#x000e1;x
(<italic>P</italic>&#x0003c;0,001), no VO<sub>2</sub>pico
(<italic>P</italic>&#x0003c;0,001) e na qualidade de vida
(<italic>P</italic>&#x0003c;0,001).</p></sec><sec><title>Conclus&#x000e3;o:</title><p>Demonstrou-se que a adi&#x000e7;&#x000e3;o do programa de treinamento muscular inspirat&#x000f3;rio,
mesmo quando aplicada por um curto per&#x000ed;odo, pode complementar os efeitos do
exerc&#x000ed;cio aer&#x000f3;bio combinado ao resistido, tornando-se uma estrat&#x000e9;gia
ben&#x000e9;fica para pacientes submetidos &#x000e0; cirurgia de revasculariza&#x000e7;&#x000e3;o do
mioc&#x000e1;rdio na Fase II da reabilita&#x000e7;&#x000e3;o card&#x000ed;aca.</p></sec></trans-abstract><kwd-group><kwd>Myocardial Revascularization</kwd><kwd>Rehabilitation</kwd><kwd>Exercise</kwd><kwd>Breathing Exercises</kwd></kwd-group></article-meta></front><body><table-wrap id="t01" orientation="portrait" position="float"><table frame="box" rules="groups"><thead><tr><th colspan="2" align="left" rowspan="1">
<bold>Abbreviations, acronyms &#x00026; symbols</bold>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">CABG</td><td align="left" rowspan="1" colspan="1">Coronary artery bypass</td></tr><tr><td align="left" rowspan="1" colspan="1">CAD</td><td align="left" rowspan="1" colspan="1">Coronary artery disease</td></tr><tr><td align="left" rowspan="1" colspan="1">CRP</td><td align="left" rowspan="1" colspan="1">Cardiac rehabilitation program</td></tr><tr><td align="left" rowspan="1" colspan="1">GCR</td><td align="left" rowspan="1" colspan="1">Group of cardiac
rehabilitation</td></tr><tr><td align="left" rowspan="1" colspan="1">IMT</td><td align="left" rowspan="1" colspan="1">Inspiratory muscle training</td></tr><tr><td align="left" rowspan="1" colspan="1">Peak VO<sub>2</sub></td><td align="left" rowspan="1" colspan="1">Peak oxygen consumption</td></tr><tr><td align="left" rowspan="1" colspan="1">PEmax</td><td align="left" rowspan="1" colspan="1">Maximal expiratory pressure</td></tr><tr><td align="left" rowspan="1" colspan="1">PImax</td><td align="left" rowspan="1" colspan="1">Maximal inspiratory pressure</td></tr><tr><td align="left" rowspan="1" colspan="1">RMS</td><td align="left" rowspan="1" colspan="1">Respiratory muscle strength</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Cardiovascular diseases are the leading cause of death and disability in Brazil and
worldwide. According to the World Health Organization, 7.3 million deaths worldwide
were due to coronary artery disease (CAD) in 2008<sup>[<xref rid="r01" ref-type="bibr">1</xref>]</sup>. According to Datasus, in Brazil in 2009 there
were 209,029 hospital admissions due to CAD, totaling 12,619 deaths with a mortality
rate of 6.04%<sup>[<xref rid="r02" ref-type="bibr">2</xref>]</sup>.</p><p>Despite advances in clinical therapy and percutaneous interventions, coronary artery
bypass grafting (CABG) is still widely used in the treatment of patients with CAD
because it can control persistent ischemia and its progression to acute myocardial
infarction, as well as provide symptomatic relief and prevent ischemic
complications<sup>[<xref rid="r03" ref-type="bibr">3</xref>]</sup>.
However, cardiac surgery is a complex procedure that triggers major organ
repercussions, which changes the physiology of patients in many
ways<sup>[<xref rid="r04" ref-type="bibr">4</xref>]</sup>.</p><p>In this sense, it has been suggested that respiratory muscle dysfunctions associated
with decreased functional capacity contribute to the prolonged period of lung
function recovery and the occurrence of physical deconditioning, which can last
several weeks in patients submitted to CABG<sup>[<xref rid="r05" ref-type="bibr">5</xref>,<xref rid="r06" ref-type="bibr">6</xref>]</sup>.</p><p>Several studies have demonstrated the effectiveness of inspiratory muscle training
(IMT) in restoration of ventilatory function, decrease in the length of hospital
stay, and improvement of functional capacity and quality of life (QoL) of patients
who underwent CABG and are in phase I cardiac rehabilitation program
(CRP)<sup>[<xref rid="r07" ref-type="bibr">7</xref>-<xref rid="r10" ref-type="bibr">10</xref>]</sup>. Onishi et al.<sup>[<xref rid="r11" ref-type="bibr">11</xref>]</sup> found that the inclusion of
resistance training combined with aerobic training for six months during phase II
CRP was beneficial to patients with metabolic syndrome submitted to CABG. However,
the short-term effects of IMT in patients in phase II CRP after CABG and its
association with aerobic and resistance training have been largely unexplored in the
literature and require further elucidation. Therefore, the aim of this study was to
investigate the efficiency of short-term IMT associated with combined aerobic and
resistance training on respiratory muscle strength (RMS), functional capacity, and
QoL in patients who underwent CABG and are in phase II CRP.</p></sec><sec sec-type="methods"><title>METHODS</title><sec><title>Study design</title><p>A prospective quasi-experimental study was conducted among patients who underwent
CABG and were recruited from the waiting list for a phase II CRP at the
Outpatient Cardiology Clinic of Hospital Universit&#x000e1;rio de Santa Maria (HUSM),
Santa Maria, RS, Brazil. The eligibility criteria included patients undergoing
CABG up to three weeks before the initiation of the study at HUSM, a clinical
course without complications during hospitalization, the absence of smoking
(previous or current), and agreement to participate. Patients with chronic
obstructive pulmonary disease, unstable angina, acute decompensated heart
failure, acute pericarditis or myocarditis, complex arrhythmias, uncontrolled
hypertension, severe orthopedic or neurological disorders, uncontrolled
diabetes, and labyrinthitis were excluded.</p><p>The study was approved by the Research Ethics Committee of Universidade Federal
de Santa Maria (UFSM) under protocol no. 16149813.3.0000.5346 and was conducted
in accordance with the Guidelines and Norms Regulating Research Involving Humans
established by Resolution no. 466/2012 of the National Health Council.</p></sec><sec><title>Patients and Intervention</title><p>Patients eligible for the study were initially assessed via anamnesis, physical
examination, and evaluation of inspiratory muscle strength. Subsequently, these
patients were randomly allocated to phase II of the CRP into two groups: a group
subjected to CRP+IMT (GCR+IMT) followed the IMT protocol in addition to the
combined training (aerobic and resistance training) and a group subjected to CRP
(GCR) followed the combined training protocol and performed breathing exercises
for 12 weeks. An RMS test was conducted before and after the intervention, and
the functional capacity and QoL were evaluated. All evaluations were conducted
by investigators blinded to the allocation of patients into the intervention
groups.</p></sec><sec><title>Cardiac Rehabilitation Program</title><p>All patients participated in the CRP for a period of 12 weeks, with two sessions
per week (24 sessions). Each session lasted 60 minutes, and all sessions were
under the direct supervision of a physical therapist. The training program
consisted of a combination of aerobic and resistance exercises, 30 minutes of
aerobic exercise on a treadmill and exercise bike, 20 minutes of resistance
exercises for the arms (latissimus dorsal m.,biceps brachii m., triceps brachii
m., deltoid m., trapezius m., pectoralis major m., pectoralis major m., and
rhomboid m) and legs (femoral quadriceps m., hip adductors m. and hip abductors
m.) with dumbbells, ankle weights, or elastic bands (3 sets of exercises for
each muscle group performed with 10 repetitions with the intensity adjusted to
50% of the load of one maximum repetition - 1MR), and 10 minutes of stretching
and relaxation. Heart rate, blood pressure, and peripheral oxygen saturation
were measured at the beginning, during, immediately after, and five minutes
after each session.</p><p>The exercise intensity was based on the percentage of heart rate reserve,
calculated as the difference between the maximum heart rate obtained in the
exercise stress test and the resting heart rate, with the establishment of an
intensity of 55%-65%<sup>[<xref rid="r12" ref-type="bibr">12</xref>]</sup> and a score of 4-6 on the modified Borg scale
(ranging between 0 and 10).</p><p>In addition to the CRP, the participants performed diaphragmatic stimulation and
fractionated breathing patterns (short inspirations during three intervals with
a mild inspiratory pause) to achieve a diaphragmatic breathing pattern similar
to that performed by the GCR+IMT.</p></sec><sec><title>Inspiratory Muscle Training</title><p>The participants assigned to the GCR+IMT group were subjected to IMT, using the
IMT Threshold<sup>&#x000ae;</sup> equipment (Threshold Inspiratory Muscle Trainer,
Health Scan Products Inc., Cedar Grove, NJ, USA) in 3 sets of 10 repetitions
with an inspiratory load of 30% of the maximal inspiratory pressure
(PImax)<sup>[<xref rid="r13" ref-type="bibr">13</xref>]</sup>.
During training, the participants remained seated with the nose occluded by a
nose clip and were advised to maintain a diaphragmatic breathing pattern and a
respiratory rate between 15 and 20 cycles per minute. Each week, the training
load was adjusted to maintain 30% of the PImax.</p></sec><sec><title>Assessment of Respiratory Muscle Strength </title><p>PImax and maximal expiratory pressure (PEmax) were measured using a digital
manometer (MVD-300, Globalmed, Porto Alegre, RS, Brazil)<sup>[<xref rid="r14" ref-type="bibr">14</xref>]</sup>. A 2-mm orifice in the
system kept the glottis open and prevented any interference from pressure
produced by facial muscles. First, the subjects were instructed to remain in a
seated position. A demonstration of how the maneuvers should be carried out was
given and then performed by the subject after the placement of a nose clip. The
subjects were instructed to keep their lips sealed tightly around the mouthpiece
so no air could escape. PImax values were obtained by inspiration from residual
volume<sup>[<xref rid="r14" ref-type="bibr">14</xref>]</sup>,
which was repeated at least three times with a one-minute interval between
repetitions. PEmax was obtained by expiration from total lung capacity, using
the same methodology applied in inspiration. During the PImax maneuver, the
subject kept the mouthpiece in the oral cavity only during the inspiration, and
in the PEmax maneuver, only during expiration.</p><p>The maneuvers were sustained at maximal force for approximately one second and
the highest value was computed from a minimum of three repetitions for each
maneuver, with a maximum difference of 10% between values and they were then
compared to the predicted values according to the equations proposed by Neder et
al.<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup>.</p></sec><sec><title>Assessment of Functional Capacity</title><p>Functional capacity was evaluated by exercise testing (ET) using a standard Bruce
protocol and assessed with peak oxygen consumption (peak VO<sub>2</sub>). The
values of peak VO<sub>2</sub> were obtained by use of a treadmill stress test
(Imbramed<sup>&#x000ae;</sup> KT 10200, Sao Paulo, Brazil), and the analysis of peak
VO<sub>2</sub> was carried out using the Ergo PC version 2.2
(Micromed<sup>TM</sup>, Brazil) software. The ET was performed according to
the guidelines of the Brazilian Society of Cardiology/Department of Exercise,
Ergometry, and Cardiovascular Rehabilitation<sup>[<xref rid="r16" ref-type="bibr">16</xref>]</sup>.</p></sec><sec><title>Evaluation of Quality of Life</title><p>QoL was assessed with the Portuguese version of the Minnesota Living with Heart
Failure Questionnaire (MLwHFQ)<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup>.</p></sec><sec><title>Sample size calculation</title><p>To estimate the sample size, a pilot study was conducted using a protocol
identical to that described above in a group of five patients. A sampling error
of 2%, a two-sided alpha of 5%, a statistical power of 80%, and a difference of
20.6&#x000b1;9.6 cmH<sub>2</sub>O in variation of PImax between the groups were
considered as well as a 10% loss to follow-up, thus resulting in the inclusion
of at least nine patients per group.</p></sec><sec><title>Statistical Analysis</title><p>Data were analyzed using the statistical software SPSS version 20.0. The
normality of the variables was assessed with the Shapiro-Wilk test. Categorical
data are presented as absolute frequencies and percentages. Continuous data with
normal distribution are expressed as means and standard deviations. Student's
t-test for paired samples was used to compare the data before and after the
intervention. The baseline data and the variation between pre- and post-CRP
values between groups were compared using the independent Student's t-test,
except for the categorical variables, which were compared by the Chi-square
test. A value of <italic>P</italic>&#x0003c;0.05 was considered statistically
significant.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>Of the 28 eligible patients, four were excluded for not meeting the inclusion
criteria. Therefore, 24 patients were included in the study. Of these, 12 patients
were allocated to the GCR and 12 were allocated to the GCR+IMT. No adverse events
were observed during the CRP and adherence to the program was considered
excellent.</p><p>The demographic, anthropometric, and clinical characteristics of both groups are
shown in <xref ref-type="table" rid="t02">Table 1</xref>. No significant differences
were observed between the two groups.</p><table-wrap id="t02" orientation="portrait" position="float"><label>Table 1</label><caption><p>Demographic and clinical characteristics of patients participating in the
study.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Baseline characteristics</th><th align="center" rowspan="1" colspan="1">GCR
(<italic>n</italic>=12)</th><th align="center" rowspan="1" colspan="1">GCR+IMT
(<italic>n</italic>=12)</th><th align="center" rowspan="1" colspan="1">
<italic>P</italic>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (years)</td><td align="center" rowspan="1" colspan="1">59.5&#x000b1;8.7</td><td align="center" rowspan="1" colspan="1">55.2&#x000b1;7.9</td><td align="center" rowspan="1" colspan="1">0.313</td></tr><tr><td align="left" rowspan="1" colspan="1">Male gender, n (%)</td><td align="center" rowspan="1" colspan="1">10 (83.3)</td><td align="center" rowspan="1" colspan="1">7 (58.3)</td><td align="center" rowspan="1" colspan="1">0.178</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI (Kg/m<sup>2</sup>)</td><td align="center" rowspan="1" colspan="1">28.4&#x000b1;3.8</td><td align="center" rowspan="1" colspan="1">30.7&#x000b1;4.4</td><td align="center" rowspan="1" colspan="1">0.274</td></tr><tr><td align="left" rowspan="1" colspan="1">Diabetes, n (%)</td><td align="center" rowspan="1" colspan="1">4 (33.33)</td><td align="center" rowspan="1" colspan="1">3 (25.0)</td><td align="center" rowspan="1" colspan="1">0.500</td></tr><tr><td align="left" rowspan="1" colspan="1">Hypertension, n (%)</td><td align="center" rowspan="1" colspan="1">4 (33.33)</td><td align="center" rowspan="1" colspan="1">5 (41.6)</td><td align="center" rowspan="1" colspan="1">0.312</td></tr><tr><td align="left" rowspan="1" colspan="1">Ejection fraction (%)</td><td align="center" rowspan="1" colspan="1">65.2&#x000b1;9.9</td><td align="center" rowspan="1" colspan="1">63.5&#x000b1;3.6</td><td align="center" rowspan="1" colspan="1">0.640</td></tr><tr><td align="left" rowspan="1" colspan="1">NYHA</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;I, n (%)</td><td align="center" rowspan="1" colspan="1">2 (16.7)</td><td align="center" rowspan="1" colspan="1">3 (25.0)</td><td align="center" rowspan="1" colspan="1">0.849</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;II, n (%)</td><td align="center" rowspan="1" colspan="1">8 (66.7)</td><td align="center" rowspan="1" colspan="1">6 (50.0)</td><td align="center" rowspan="1" colspan="1">0.408</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;III, n (%)</td><td align="center" rowspan="1" colspan="1">2 (16.7)</td><td align="center" rowspan="1" colspan="1">3 (25.0)</td><td align="center" rowspan="1" colspan="1">0.849</td></tr><tr><td align="left" rowspan="1" colspan="1">Extent of disease (%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">2-vessel</td><td align="center" rowspan="1" colspan="1">54.3</td><td align="center" rowspan="1" colspan="1">50.5</td><td align="center" rowspan="1" colspan="1">0.285</td></tr><tr><td align="left" rowspan="1" colspan="1">3-vessel</td><td align="center" rowspan="1" colspan="1">45.7</td><td align="center" rowspan="1" colspan="1">49.5</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Extracorporeal circulation, n
(%)</td><td align="center" rowspan="1" colspan="1">12 (100)</td><td align="center" rowspan="1" colspan="1">12 (100)</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Duration of hospitalization
after surgery (days)</td><td align="center" rowspan="1" colspan="1">6.7&#x000b1;1.7</td><td align="center" rowspan="1" colspan="1">7.1&#x000b1;1.5</td><td align="center" rowspan="1" colspan="1">0.657</td></tr><tr><td align="left" rowspan="1" colspan="1">Peak VO<sub>2</sub>
(mL.Kg<sup>1</sup>.min<sup>-1</sup>)</td><td align="center" rowspan="1" colspan="1">26.0&#x000b1;5.6</td><td align="center" rowspan="1" colspan="1">25.5&#x000b1;3.7</td><td align="center" rowspan="1" colspan="1">0.802</td></tr><tr><td align="left" rowspan="1" colspan="1">Peak VO<sub>2</sub><sup>2</sup>
(% predicted)</td><td align="center" rowspan="1" colspan="1">88.1&#x000b1;23.0</td><td align="center" rowspan="1" colspan="1">86.4&#x000b1;16.0</td><td align="center" rowspan="1" colspan="1">0.836</td></tr><tr><td align="left" rowspan="1" colspan="1">PImax
(c<sup>2</sup>mH<sub>2</sub>O)</td><td align="center" rowspan="1" colspan="1">72.0&#x000b1;8.1</td><td align="center" rowspan="1" colspan="1">67.8&#x000b1;9.0</td><td align="center" rowspan="1" colspan="1">0.782</td></tr><tr><td align="left" rowspan="1" colspan="1">PImax (% predicted)</td><td align="center" rowspan="1" colspan="1">71.4&#x000b1;13.8</td><td align="center" rowspan="1" colspan="1">70.4&#x000b1;11.1</td><td align="center" rowspan="1" colspan="1">0.856</td></tr><tr><td align="left" rowspan="1" colspan="1">PEmax (cmH<sub>2</sub>O)</td><td align="center" rowspan="1" colspan="1">87.3&#x000b1;11.0</td><td align="center" rowspan="1" colspan="1">86.6&#x000b1;25.9</td><td align="center" rowspan="1" colspan="1">0.936</td></tr><tr><td align="left" rowspan="1" colspan="1">PEmax (% predicted)</td><td align="center" rowspan="1" colspan="1">80.2&#x000b1;13.9</td><td align="center" rowspan="1" colspan="1">86.1&#x000b1;27.7</td><td align="center" rowspan="1" colspan="1">0.518</td></tr><tr><td align="left" rowspan="1" colspan="1">MLwHFQ (score)</td><td align="center" rowspan="1" colspan="1">39.9&#x000b1;12.6</td><td align="center" rowspan="1" colspan="1">41.0&#x000b1;19.0</td><td align="center" rowspan="1" colspan="1">0.871</td></tr><tr><td align="left" rowspan="1" colspan="1">Medication, n (%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Acetylsalicylic acid</td><td align="center" rowspan="1" colspan="1">8 (66.6)</td><td align="center" rowspan="1" colspan="1">6 (50.0)</td><td align="center" rowspan="1" colspan="1">0.408</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Clopidogrel or
triclopidine</td><td align="center" rowspan="1" colspan="1">2 (16.7)</td><td align="center" rowspan="1" colspan="1">1 (8.3)</td><td align="center" rowspan="1" colspan="1">0.500</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Statin</td><td align="center" rowspan="1" colspan="1">6 (50.0)</td><td align="center" rowspan="1" colspan="1">6 (50.0)</td><td align="center" rowspan="1" colspan="1">1.000</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Diuretics</td><td align="center" rowspan="1" colspan="1">4 (33.3)</td><td align="center" rowspan="1" colspan="1">3 (25.0)</td><td align="center" rowspan="1" colspan="1">0.500</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Warfarin</td><td align="center" rowspan="1" colspan="1">1 (8.3)</td><td align="center" rowspan="1" colspan="1">2 (16.7)</td><td align="center" rowspan="1" colspan="1">0.500</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;ACEI or ARB</td><td align="center" rowspan="1" colspan="1">4 (33.3)</td><td align="center" rowspan="1" colspan="1">5 (41.6)</td><td align="center" rowspan="1" colspan="1">0.500</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Beta-blockers</td><td align="center" rowspan="1" colspan="1">8 (66.6)</td><td align="center" rowspan="1" colspan="1">9 (75.0)</td><td align="center" rowspan="1" colspan="1">1.000</td></tr></tbody></table><table-wrap-foot><fn id="TFN01"><p>Data are expressed as mean &#x000b1; standard deviation or absolute values and
percentages.</p></fn><fn id="TFN02"><p>ACEI=angiotensin-converting enzyme inhibitor; ARB=angiotensin II receptor
blocker; BMI=body mass index; GCR=cardiac rehabilitation group;
GCR+IMT=cardiac rehabilitation group + inspiratory muscle training
program; MLwHFQ=Minnesota living with heart failure questionnaire;
NYHA=New York Heart Association; Peak VO2=peak oxygen consumption;
PEmax=maximal expiratory pressure; PImax=maximal inspiratory
pressure</p></fn></table-wrap-foot></table-wrap><p>A significant increase in PImax and PEmax was observed after CRP in both groups.
However, the variation between pre- and post-CRP values was significantly higher in
the GCR+IMT (<xref ref-type="table" rid="t03">Table 2</xref>).</p><table-wrap id="t03" orientation="portrait" position="float"><label>Table 2</label><caption><p>Comparison of respiratory muscle strength between groups.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Variables</th><th colspan="4" align="center" rowspan="1">GCR (n=12)</th><th colspan="4" align="center" rowspan="1">GCR+IMT (n=12)</th><th align="center" rowspan="1" colspan="1">&#x000a0;</th></tr><tr><th align="left" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">Pre</th><th align="center" rowspan="1" colspan="1">Post</th><th align="center" rowspan="1" colspan="1">Variation</th><th align="center" rowspan="1" colspan="1"><italic>P</italic>*</th><th align="center" rowspan="1" colspan="1">Pre</th><th align="center" rowspan="1" colspan="1">Post </th><th align="center" rowspan="1" colspan="1">Variation</th><th align="center" rowspan="1" colspan="1">
<italic>P</italic>
<xref ref-type="table-fn" rid="TFN05">*</xref>
</th><th align="center" rowspan="1" colspan="1">
<italic>P</italic>
<xref ref-type="table-fn" rid="TFN06">**</xref>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">PEmax (cmH<sub>2</sub>O)</td><td align="center" rowspan="1" colspan="1">87.3&#x000b1;11.0</td><td align="center" rowspan="1" colspan="1">89.8&#x000b1;10.5</td><td align="center" rowspan="1" colspan="1">2.3&#x000b1;0.8</td><td align="center" rowspan="1" colspan="1">0.004 </td><td align="center" rowspan="1" colspan="1">86.6&#x000b1;25.9</td><td align="center" rowspan="1" colspan="1">108.1 &#x000b1;17.1</td><td align="center" rowspan="1" colspan="1">21.5&#x000b1;8.5</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001 </td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">PEmax (% predicted) </td><td align="center" rowspan="1" colspan="1">80.2&#x000b1;13.9 </td><td align="center" rowspan="1" colspan="1">82.2&#x000b1;15.6 </td><td align="center" rowspan="1" colspan="1">2.5&#x000b1;0.8</td><td align="center" rowspan="1" colspan="1">0.038</td><td align="center" rowspan="1" colspan="1">86.1&#x000b1;27.7</td><td align="center" rowspan="1" colspan="1">108.1&#x000b1;21.1</td><td align="center" rowspan="1" colspan="1">22.0&#x000b1;7.7</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">PImax (cmH<sub>2</sub>O) </td><td align="center" rowspan="1" colspan="1">72.0&#x000b1;8.3</td><td align="center" rowspan="1" colspan="1">77.0&#x000b1;5.8 </td><td align="center" rowspan="1" colspan="1">4.9&#x000b1;0.2 </td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" rowspan="1" colspan="1">67.8&#x000b1;9.0 </td><td align="center" rowspan="1" colspan="1">96.7&#x000b1;21.3 </td><td align="center" rowspan="1" colspan="1">28.9&#x000b1;7.9</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.00</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">PImax (% predicted)</td><td align="center" rowspan="1" colspan="1"> 71.4&#x000b1;13.8</td><td align="center" rowspan="1" colspan="1">76.4&#x000b1;12.8</td><td align="center" rowspan="1" colspan="1"> 4.7&#x000b1;0.9</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" rowspan="1" colspan="1"> 70.4&#x000b1;11.1</td><td align="center" rowspan="1" colspan="1"> 99.6&#x000b1;16.7</td><td align="center" rowspan="1" colspan="1"> 29.1&#x000b1;5.6</td><td align="center" rowspan="1" colspan="1">1 &#x0003c;0.001</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr></tbody></table><table-wrap-foot><fn id="TFN03"><p>Data are expressed as mean &#x000b1; standard deviation.</p></fn><fn id="TFN04"><p>GCR=cardiac rehabilitation group; GCR+IMT=cardiac rehabilitation group +
inspiratory muscle training program; PEmax=maximal expiratory pressure;
Pimax=maximal inspiratory pressure</p></fn><fn id="TFN05"><label>*</label><p>P-value derived using paired Student&#x02019;s t-test, after checking for normal
distributions.</p></fn><fn id="TFN06"><label>**</label><p>P-value derived using independent Student&#x02019;s t-test for comparison of
variation between the groups.</p></fn></table-wrap-foot></table-wrap><p>Regarding functional capacity, it was observed that in the pre-CRP phase, the GCR
group achieved approximately 88% of predicted peak VO<sub>2</sub> whereas patients
in the GCR+IMT achieved approximately 86% (<xref ref-type="table" rid="t02">Table
1</xref>). After intervention, patients in the GCR + IMT improved significantly
their peak VO<sub>2</sub>. Additionally, the variation of peak VO<sub>2</sub> was
significantly higher in the GCR+TMI compared to the GCR, and a similar result was
demonstrated for the percent-predicted peak VO<sub>2</sub> (% predicted peak
VO<sub>2</sub>) (<xref ref-type="fig" rid="f01">Figures 1</xref> and <xref ref-type="fig" rid="f02">2</xref>).</p><fig id="f01" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Comparison of peak oxygen consumption (peak VO<sub>2</sub>) between
groups.</p></caption><graphic xlink:href="rbccv-30-04-0474-g01"/></fig><fig id="f02" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Comparison of peak oxygen consumption (% predicted) between groups.</p></caption><graphic xlink:href="rbccv-30-04-0474-g02"/></fig><p>The total MLwHFQ scores decreased significantly in both groups, indicating
improvement in QoL, however, the variation in MLwHFQ scores was significantly higher
in the GCR + IMT (<xref ref-type="fig" rid="f03">Figure 3</xref>).</p><fig id="f03" orientation="portrait" position="float"><label>Fig. 3</label><caption><p>Comparison of change in QoL score, assessed with Minnesota Living with Heart
Failure questionnaire (MLwHFQ), between groups.</p></caption><graphic xlink:href="rbccv-30-04-0474-g03"/></fig></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>The present study found that a short-term IMT program associated with combined
aerobic and resistance training had a more pronounced effect on respiratory muscle
strength, functional capacity and QoL than combined aerobic and resistance training
alone in patients who underwent CABG surgery and are in phase II CRP. To the best of
our knowledge, this is the first study to address the additional short-term effects
of IMT associated with combined training in this patient population.</p><p>Despite the current lack of evidence demonstrating the benefits of IMT in patients
who underwent CABG surgery and are in phase II CRP, it is important to mention the
pioneering study of Winkelmann et al.<sup>[<xref rid="r18" ref-type="bibr">18</xref>]</sup>, which also investigated the potential additional
benefits of IMT combined with aerobic training for 12 weeks, although in a different
population (patients with chronic heart failure - CHF). Their study demonstrated
that the addition of IMT to aerobic exercise resulted in additional improvement in
PImax compared to aerobic exercise alone, and these results were similar to those
reported in this study. Recently, Laoutaris et al.<sup>[<xref rid="r19" ref-type="bibr">19</xref>]</sup>, using a protocol similar to ours, showed that
IMT associated with combined aerobic and resistance training in 27 patients with
CHF, without inspiratory muscle weakness, is safe, and resulted in incremental
benefits in PImax compared with the effects of aerobic training alone.</p><p>Studies have been conducted to evaluated the effects of combined aerobic and
resistance training on functional capacity of patients undergoing CABG. Onishi et
al.<sup>[<xref rid="r11" ref-type="bibr">11</xref>]</sup> and Sumide
et al.<sup>[<xref rid="r20" ref-type="bibr">20</xref>]</sup> showed that
combined training induced significant improvement in peak VO<sub>2</sub> in this
patient population. In contrast, Arthur et al.<sup>[<xref rid="r21" ref-type="bibr">21</xref>]</sup>, in a randomized controlled trial to compare the
effect of 6 months of combined aerobic and resistance training vs aerobic training
alone in women undergoing CABG, reported that after the exercise training program
both groups showed statistically significant improvements in peak
VO<sub>2</sub>.</p><p>In the present study, even over a relatively short-term period, it was observed that
IMT associated with combined aerobic and resistance training provides a significant
improvement in functional capacity when compared to combined training. These results
indicate that the addition of IMT may have complementary effects to those obtained
with combined training on functional capacity of patients who underwent CABG and are
in phase II CRP. One potential explanation of this finding is that the IMT program,
even over a short-term period, improves systemic vasodilation and perfusion of
peripheral muscles<sup>[<xref rid="r22" ref-type="bibr">22</xref>]</sup>,
promoting a more pronounced effect on functional capacity in these patients.
Laoutaris et al.<sup>[<xref rid="r23" ref-type="bibr">23</xref>]</sup>
showed that addition of IMT program to aerobic training in patients with ventricular
assist device resulted in an additional improvement in peak VO<sub>2</sub>, compared
with the effects of aerobic training alone.</p><p>Regarding QoL, the values of MLwHFQ scores improved significantly in both groups.
However, the IMT group showed a higher variation in MLwFQ scores. These changes may
explain the additional improvement in QoL with IMT associated with combined
training. Few studies have evaluated the impact of IMT associated with aerobic and
resistance training on QoL specifically in patients who underwent CABG and are in
phase II CRP. The addition of IMT to training programs is becoming more widespread
as a potential non-pharmacological therapeutic intervention to improve QoL of
patients with CHF<sup>[<xref rid="r18" ref-type="bibr">18</xref>,<xref rid="r19" ref-type="bibr">19</xref>]</sup>.
Recently, Adamopoulos et al.<sup>[<xref rid="r24" ref-type="bibr">24</xref>]</sup>, in a 12-week prospective randomized multicenter study,
have reported that IMT associated with aerobic training improves QoL in patients
with CHF.</p><p>We consider that our results are relevant because even a short-term IMT program
performed just twice a week with a lower inspiratory resistive loading intensity
improved the variables analyzed, although it was carried out in patients without
respiratory muscle weakness. Furthermore, these findings are consistent with results
of previous studies conducted with patients with CHF subjected to the IMT program,
though performed at higher weekly frequency and with a higher inspiratory loading
intensity training protocol.</p><p>Some study limitations should be considered. First, our sample included only 24
patients submitted to CABG. However, it is of note that the number of patients who
participate in phase II CRP in Brazil is extremely low. Second, an inspiratory
muscle endurance testing was not performed. The third limitation is related to
learning the technique of assessment of respiratory muscle strength. This test
depends on the understanding and cooperation of participating individuals.
Therefore, the technique can have a determinative positive effect on the outcome.
This aspect can be considered as qualitatively influencing the results of the
present study.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>This study demonstrates that a short-term IMT program associated with aerobic and
resistance training in patients undergoing phase II of a CRP after CABG resulted in
significantly large increments in respiratory muscle strength, functional capacity,
and QoL. Our single-center findings also indicate that the addition of IMT, even
when applied for a short period, can complement and enhance the effects of combined
aerobic and resistance training and could become a simple and inexpensive adjuvant
treatment, improving the efficiency of phase II cardiac rehabilitation programs
within the public health system. Future large multicenter studies are needed to
provide definitive proof of these benefits.</p><table-wrap id="t04" orientation="portrait" position="float"><table frame="box" rules="groups"><thead><tr><th colspan="2" align="left" rowspan="1">
<bold>Authors&#x02019; roles &#x00026;&#x000a0;responsibilities</bold>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">BMH</td><td align="left" rowspan="1" colspan="1">Analysis and/or interpretation
of data; final approval of the manuscript; study design;
implementation of projects and/ or experiments; manuscript writing
or critical review of its content</td></tr><tr><td align="left" rowspan="1" colspan="1">DMC</td><td align="left" rowspan="1" colspan="1">Analysis and/or interpretation
of data; statistical analysis; final approval of the manuscript;
manuscript writing or critical review of its content</td></tr><tr><td align="left" rowspan="1" colspan="1">TJNG</td><td align="left" rowspan="1" colspan="1">Final approval of the
manuscript; study design; implemen-tation of projects and/or
experiments; manuscript writing or critical review of its
content</td></tr><tr><td align="left" rowspan="1" colspan="1">TDS</td><td align="left" rowspan="1" colspan="1">Final approval of the
manuscript; implementation of projects and/or experiments;
manuscript writing or critical review of its content</td></tr><tr><td align="left" rowspan="1" colspan="1">MSV</td><td align="left" rowspan="1" colspan="1">Final approval of the
manuscript; implementation of projects and/or experiments;
manuscript writing or critical review of its content</td></tr><tr><td align="left" rowspan="1" colspan="1">SNP</td><td align="left" rowspan="1" colspan="1">Final approval of the
manuscript; study design; manuscript writing or critical review of
its content</td></tr><tr><td align="left" rowspan="1" colspan="1">VAB</td><td align="left" rowspan="1" colspan="1">Final approval of the
manuscript; study design; manuscript writing or critical review of
its content</td></tr><tr><td align="left" rowspan="1" colspan="1">IMA</td><td align="left" rowspan="1" colspan="1">Analysis and/or interpretation
of data; Statistical analysis; final approval of the manuscript;
study design; manuscript writing or critical review of its
content</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="other"><p>Work carried out at the Department of Physiotherapy and Rehabilitation of the
Universidade Federal de Santa Maria (UFSM), Santa Maria, RS, Brazil.</p></fn><fn fn-type="supported-by"><p>Financial support: Programa de Aux&#x000ed;lio &#x000e0; Pesquisa de Rec&#x000e9;m-Doutores da
Universidade Federal de Santa Maria/Universidade Federal de Santa Maria&#x02019;s
Research Support to Young Researchers Program</p></fn><fn fn-type="other"><p>
<bold>Source of funding</bold>
</p><p>This study was financially supported by the Research Funding Program
(FIPE)/UFSM.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r01"><label>1</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><source>Global atlas on cardiovascular disease prevention and control</source><publisher-loc>Geneva</publisher-loc><publisher-name>World Health Organization</publisher-name><year>2011</year></element-citation></ref><ref id="r02"><label>2</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>Brasil</collab><collab>Minist&#x000e9;rio da Sa&#x000fa;de</collab><collab>Datasus</collab></person-group><source>Banco de dados do Sistema &#x000fa;nico de Sa&#x000fa;de</source><year>2010</year><date-in-citation content-type="access-date">2015 Jul 20</date-in-citation><comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.datasus.gov.br">http://www.datasus.gov.br</ext-link></comment></element-citation></ref><ref id="r03"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Sociedade Brasileira de Cardiologia</collab></person-group><article-title>Guidelines for Unstable Angina and Non-ST-Segment Elevation
Myocardial Infarction of the Brazilian Society of Cardiology (II Edition,
2007)</article-title><source>Arq Bras Cardiol</source><year>2007</year><volume>89</volume><issue>4</issue><supplement>Suppl 1</supplement><fpage>e89</fpage><lpage>131</lpage><pub-id pub-id-type="pmid">17992375</pub-id></element-citation></ref><ref id="r04"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smetana</surname><given-names>GW</given-names></name></person-group><article-title>Postoperative pulmonary complications: an update on risk
assessment and reduction</article-title><source>Cleve Clin J Med</source><year>2009</year><volume>76</volume><issue>4</issue><fpage>S60</fpage><lpage>S65</lpage><pub-id pub-id-type="pmid">19880838</pub-id></element-citation></ref><ref id="r05"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borges-Santos</surname><given-names>EB</given-names></name><name><surname>Genz</surname><given-names>IC</given-names></name><name><surname>Longo</surname><given-names>AF</given-names></name><name><surname>Hayashi</surname><given-names>D</given-names></name><name><surname>Gon&#x000e7;alves</surname><given-names>CG</given-names></name><name><surname>Bellinetti</surname><given-names>MB</given-names></name><etal/></person-group><article-title>Comportamento da fun&#x000e7;&#x000e3;o pulmonar, for&#x000e7;a muscular respirat&#x000f3;ria e
qualidade de vida em pacientes submetidos &#x000e0;s toracotomias
eletivas</article-title><source>Rev Col Bras Cir</source><year>2012</year><volume>39</volume><issue>1</issue><fpage>4</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">22481699</pub-id></element-citation></ref><ref id="r06"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ades</surname><given-names>PA</given-names></name><name><surname>Savage</surname><given-names>PD</given-names></name><name><surname>Brawner</surname><given-names>CA</given-names></name><name><surname>Lyon</surname><given-names>CE</given-names></name><name><surname>Ehrman</surname><given-names>JK</given-names></name><name><surname>Bunn</surname><given-names>JY</given-names></name><etal/></person-group><article-title>Aerobic capacity in patients entering cardiac
rehabilitation</article-title><source>Circulation</source><year>2006</year><volume>113</volume><issue>23</issue><fpage>2706</fpage><lpage>2712</lpage><pub-id pub-id-type="pmid">16754799</pub-id></element-citation></ref><ref id="r07"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barros</surname><given-names>GF</given-names></name><name><surname>Santos</surname><given-names>CS</given-names></name><name><surname>Granado</surname><given-names>FB</given-names></name><name><surname>Costa</surname><given-names>PT</given-names></name><name><surname>L&#x000ed;maco</surname><given-names>RP</given-names></name><name><surname>Gardenghi</surname><given-names>G</given-names></name></person-group><article-title>Respiratory muscle training in patients submitted to coronary
arterial bypass graft</article-title><source>Rev Bras Cir Cardiovasc</source><year>2010</year><volume>25</volume><issue>4</issue><fpage>483</fpage><lpage>489</lpage><pub-id pub-id-type="pmid">21340377</pub-id></element-citation></ref><ref id="r08"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savci</surname><given-names>S</given-names></name><name><surname>Degirmenci</surname><given-names>B</given-names></name><name><surname>Saglam</surname><given-names>M</given-names></name><name><surname>Arikan</surname><given-names>H</given-names></name><name><surname>Inal-Ince</surname><given-names>D</given-names></name><name><surname>Turan</surname><given-names>HN</given-names></name><etal/></person-group><article-title>Short-term effects of inspiratory muscle training in coronary
artery bypass graft surgery: a randomized controlled trial</article-title><source>Scand Cardiovasc J</source><year>2011</year><volume>45</volume><issue>5</issue><fpage>286</fpage><lpage>293</lpage><pub-id pub-id-type="pmid">21793631</pub-id></element-citation></ref><ref id="r09"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferreira</surname><given-names>PEG</given-names></name><name><surname>Rodrigues</surname><given-names>AJ</given-names></name><name><surname>&#x000c9;vora</surname><given-names>PRB</given-names></name></person-group><article-title>Efeitos de um programa de reabilita&#x000e7;&#x000e3;o da musculatura
inspirat&#x000f3;ria no p&#x000f3;s-operat&#x000f3;rio de cirurgia card&#x000ed;aca</article-title><source>Arq Bras Cardiol</source><year>2009</year><volume>92</volume><issue>4</issue><fpage>275</fpage><lpage>282</lpage><pub-id pub-id-type="pmid">19565135</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matheus</surname><given-names>GB</given-names></name><name><surname>Dragosavac</surname><given-names>D</given-names></name><name><surname>Trevisan</surname><given-names>P</given-names></name><name><surname>Costa</surname><given-names>CE</given-names></name><name><surname>Lopes</surname><given-names>MM</given-names></name><name><surname>Ribeiro</surname><given-names>GC</given-names></name></person-group><article-title>Inspiratory muscle training improves tidal volume and vital
capacity after CABG surgery</article-title><source>Rev Bras Cir Cardiovasc</source><year>2012</year><volume>27</volume><issue>3</issue><fpage>362</fpage><lpage>369</lpage><pub-id pub-id-type="pmid">23288176</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Onishi</surname><given-names>T</given-names></name><name><surname>Shimada</surname><given-names>K</given-names></name><name><surname>Sunayama</surname><given-names>S</given-names></name><name><surname>Ohmura</surname><given-names>H</given-names></name><name><surname>Sumide</surname><given-names>T</given-names></name><name><surname>Masaki</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Effects of cardiac rehabilitation in patients with metabolic
syndrome after coronary artery bypass grafting</article-title><source>J Cardiol</source><year>2009</year><volume>53</volume><issue>3</issue><fpage>381</fpage><lpage>387</lpage><pub-id pub-id-type="pmid">19477380</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Mahler</surname><given-names>DA</given-names></name><collab>American College of Sports Medicine</collab></person-group><source>ACSM's guidelines for exercise testing and prescription,</source><edition>5th ed</edition><publisher-loc>Baltimore</publisher-loc><publisher-name>Williams &#x00026;amp; Wilkins</publisher-name><year>1995</year></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dall'Ago</surname><given-names>P</given-names></name><name><surname>Chiappa</surname><given-names>GR</given-names></name><name><surname>Guths</surname><given-names>H</given-names></name><name><surname>Stein</surname><given-names>R</given-names></name><name><surname>Ribeiro</surname><given-names>JP</given-names></name></person-group><article-title>Inspiratory muscle training in patients with heart failure and
inspiratory muscle weakness: a randomized trial</article-title><source>J Am Coll Cardiol</source><year>2006</year><volume>47</volume><issue>4</issue><fpage>757</fpage><lpage>763</lpage><pub-id pub-id-type="pmid">16487841</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>American Thoracic Society/European Respiratory Society</collab></person-group><article-title>ATS/ERS Statement on respiratory muscle testing</article-title><source>Am J Resp Crit Care Med</source><year>2002</year><volume>166</volume><issue>4</issue><fpage>518</fpage><lpage>624</lpage><pub-id pub-id-type="pmid">12186831</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neder</surname><given-names>JA</given-names></name><name><surname>Andreoni</surname><given-names>S</given-names></name><name><surname>Lerario</surname><given-names>MC</given-names></name><name><surname>Nery</surname><given-names>LE</given-names></name></person-group><article-title>Reference values for lung function tests. II. Maximal respiratory
pressures and voluntary ventilation</article-title><source>Braz J Med Biol Res</source><year>1999</year><volume>32</volume><issue>6</issue><fpage>719</fpage><lpage>727</lpage><pub-id pub-id-type="pmid">10412550</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meneghelo</surname><given-names>RS</given-names></name><name><surname>Ara&#x000fa;jo</surname><given-names>CGS</given-names></name><name><surname>Stein</surname><given-names>R</given-names></name><name><surname>Mastrocolla</surname><given-names>LE</given-names></name><name><surname>Albuquerque</surname><given-names>PF</given-names></name><name><surname>Serra</surname><given-names>SM</given-names></name><etal/><collab>Sociedade Brasileira de Cardiologia</collab></person-group><article-title>III Diretrizes sobre teste ergom&#x000e9;trico</article-title><source>Arq Bras Cardiol</source><year>2010</year><volume>95</volume><issue>5 </issue><supplement> 1</supplement><fpage>1</fpage><lpage>26</lpage></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carvalho</surname><given-names>VO</given-names></name><name><surname>Guimar&#x000e3;es</surname><given-names>GV</given-names></name><name><surname>Carrara</surname><given-names>D</given-names></name><name><surname>Bacal</surname><given-names>F</given-names></name><name><surname>Bocchi</surname><given-names>EA</given-names></name></person-group><article-title>Valida&#x000e7;&#x000e3;o da vers&#x000e3;o em portugu&#x000ea;s do Minnesota Living with Heart
Failure Questionnaire</article-title><source>Arq Bras Cardiol</source><year>2009</year><volume>93</volume><issue>1</issue><fpage>39</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">19838469</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winkelmann</surname><given-names>ER</given-names></name><name><surname>Chiappa</surname><given-names>GR</given-names></name><name><surname>Lima</surname><given-names>CO</given-names></name><name><surname>Viecili</surname><given-names>PR</given-names></name><name><surname>Stein</surname><given-names>R</given-names></name><name><surname>Ribeiro</surname><given-names>JP</given-names></name></person-group><article-title>Addition of inspiratory muscle training to aerobic training
improves cardiorespiratory responses to exercise in patients with heart
failure and inspiratory muscle weakness</article-title><source>Am Heart J</source><year>2009</year><volume>158</volume><issue>5</issue><fpage>768</fpage><lpage>768</lpage><fpage>e1</fpage><lpage>e7</lpage><pub-id pub-id-type="pmid">19853695</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laoutaris</surname><given-names>ID</given-names></name><name><surname>Adamopoulos</surname><given-names>S</given-names></name><name><surname>Manginas</surname><given-names>A</given-names></name><name><surname>Panagiotakos</surname><given-names>DB</given-names></name><name><surname>Kallistratos</surname><given-names>MS</given-names></name><name><surname>Doulaptsis</surname><given-names>C</given-names></name><etal/></person-group><article-title>Benefits of combined aerobic/resistance/inspiratory training in
patients with chronic heart failure. A complete exercise model? A
prospective randomised study</article-title><source>Int J Cardiol</source><year>2013</year><volume>167</volume><issue>5</issue><fpage>1967</fpage><lpage>1972</lpage><pub-id pub-id-type="pmid">22658571</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sumide</surname><given-names>T</given-names></name><name><surname>Shimada</surname><given-names>K</given-names></name><name><surname>Ohmura</surname><given-names>H</given-names></name><name><surname>Onishi</surname><given-names>T</given-names></name><name><surname>Kawakami</surname><given-names>K</given-names></name><name><surname>Masaki</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Relationship between exercise tolerance and muscle strength
following cardiac rehabilitation: comparison of patients after cardiac
surgery and patients with myocardial infarction</article-title><source>J Cardiol</source><year>2009</year><volume>54</volume><issue>2</issue><fpage>273</fpage><lpage>281</lpage><pub-id pub-id-type="pmid">19782265</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arthur</surname><given-names>HM</given-names></name><name><surname>Gunn</surname><given-names>E</given-names></name><name><surname>Thorpe</surname><given-names>KE</given-names></name><name><surname>Ginis</surname><given-names>KM</given-names></name><name><surname>Mataseje</surname><given-names>L</given-names></name><name><surname>McCartney</surname><given-names>N</given-names></name><etal/></person-group><article-title>Effect of aerobic vs combined aerobic-strength training on
1-year, post-cardiac rehabilitation outcomes in women after a cardiac
event</article-title><source>J Rehabil Med</source><year>2007</year><volume>39</volume><issue>9</issue><fpage>730</fpage><lpage>735</lpage><pub-id pub-id-type="pmid">17999012</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiappa</surname><given-names>GR</given-names></name><name><surname>Roseguini</surname><given-names>BT</given-names></name><name><surname>Vieira</surname><given-names>PJ</given-names></name><name><surname>Alves</surname><given-names>CN</given-names></name><name><surname>Tavares</surname><given-names>A</given-names></name><name><surname>Winkelmann</surname><given-names>ER</given-names></name><etal/></person-group><article-title>Inspiratory muscle training improves blood flow to resting and
exercising limbs in patients with chronic heart failure</article-title><source>J Am Coll Cardiol</source><year>2008</year><volume>51</volume><issue>17</issue><fpage>1663</fpage><lpage>1671</lpage><pub-id pub-id-type="pmid">18436118</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laoutaris</surname><given-names>ID</given-names></name><name><surname>Dritsas</surname><given-names>A</given-names></name><name><surname>Adamopoulos</surname><given-names>S</given-names></name><name><surname>Manginas</surname><given-names>A</given-names></name><name><surname>Gouziouta</surname><given-names>A</given-names></name><name><surname>Kallistratos</surname><given-names>MS</given-names></name><etal/></person-group><article-title>Benefits of physical training on exercise capacity, inspiratory
muscle function, and quality of life in patients with ventricular assist
devices long-term postimplantation</article-title><source>Eur J Cardiovasc Prev Rehabil</source><year>2011</year><volume>18</volume><issue>1</issue><fpage>33</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">20571404</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adamopoulos</surname><given-names>S</given-names></name><name><surname>Schmid</surname><given-names>J</given-names></name><name><surname>Dendale</surname><given-names>P</given-names></name><name><surname>Poerschke</surname><given-names>D</given-names></name><name><surname>Hansen</surname><given-names>D</given-names></name><name><surname>Dritsas</surname><given-names>A</given-names></name><etal/></person-group><article-title>Combined aerobic/inspiratory muscle training vs. aerobic training
in patients with chronic heart failure: The Vent-HeFT trial: a European
prospective multicentre randomized trial</article-title><source>Eur J Heart Fail</source><year>2014</year><volume>16</volume><issue>5</issue><fpage>574</fpage><lpage>582</lpage><pub-id pub-id-type="pmid">24634346</pub-id></element-citation></ref></ref-list></back></article>